Shift Work Sleep Disorder drains workers—and bills employers

Shift Work Sleep Disorder affects up to 40% of U.S. shift workers, causing insomnia, chronic fatigue, and impaired concentration. Yet many go undiagnosed for years because traditional sleep-clinic pathways clash with night-shift schedules. The result isn’t onl

Before most of America pours its first cup of coffee, millions of workers are already hours into their shifts, and they’re tired.

Overnight warehouse teams are packing orders. Early-morning bus drivers are taking kids to school. ER nurses are handing off to the day team at 7 a.m. For many, the fatigue isn’t just a side effect of long hours. It can be a diagnosable condition—Shift Work Sleep Disorder. or SWSD—that too often goes recognized late. or not at all.

SWSD affects up to 40% of U.S. shift workers. It can cause persistent insomnia, chronic fatigue, and impaired concentration. When it’s left untreated, the effects can compound: an increased risk of depression, Type 2 diabetes, and cardiovascular disease. The workplace consequences follow a similar arc. with higher absenteeism. more on-the-job errors. and greater injury risk—especially in logistics. healthcare. and transportation. where precision and reliability can’t be left to chance.

Treating SWSD is possible. The stumbling block is access.

Getting diagnosed with a sleep disorder requires navigating a system built around schedules that don’t fit hourly work. The standard diagnostic pathway is an overnight polysomnography (PSG) study at a sleep clinic. But those studies require patients to arrive during hours that clash with night-shift routines. With one trained sleep specialist for every 43. 000 Americans. the wait time for a referral and an initial appointment can stretch for months.

That friction adds up at every step. The employee who works nights often lacks the scheduling flexibility that salaried workers may have. The gap isn’t simply that care is hard to find—it’s that the system is structurally mismatched with the industries where shift-work sleep problems are concentrated.

The outcome is predictable, even if it isn’t talked about: a large population cycling through impaired work performance, fatigue, and eventually preventable chronic illness—without receiving the intervention that could break the pattern.

The economic case is equally direct. Employers in logistics. healthcare. transportation. and retail are dealing with an underrecognized liability: workers living with untreated SWSD aren’t abstract figures. They’re the overnight warehouse team processing next-day orders. They’re nurses working back-to-back 12-hour nights. They’re long-haul drivers whose alertness can be a matter of public safety.

One 2016 study conducted by the American Academy of Sleep Medicine put a concrete number on the broader cost of undiagnosed sleep apnea among U.S. adults: about $150B annually. That estimate includes $87B in lost productivity, $26B in motor vehicle accidents, and $6.5B in workplace accidents. The National Safety Council estimates that individual employees with untreated sleep apnea generate about $3,000 more per year in healthcare costs. Each untreated case can also carry associated risks such as cardiovascular events, diabetes, and mental health crises.

The numbers underscore a central tension in many workplaces: the assumption that workers simply won’t engage with sleep health programs. That assumption overlooks how access changes behavior. An at-home sleep study removes the scheduling barriers that prevent many night-shift workers from completing clinic-based pathways. For workers who can’t clear an evening for an overnight lab study. the difference isn’t convenience—it’s whether diagnosis happens at all.

What employers can do starts with choices, not research.

First, normalize screening. Routine sleep health screening should be offered as part of annual wellness programs or onboarding. SWSD symptoms aren’t always obvious. and many workers view chronic fatigue as a casualty of their job rather than a medical problem. Low-friction screening can catch the people who would never self-refer.

Second, update benefits design. Covering at-home diagnostics and digital care pathways isn’t a perk aimed at convenience. For a population that can’t navigate the traditional system, it’s the only way to make sleep medicine accessible.

Third, treat it as a retention play, not just a wellness benefit. In industries facing persistent labor shortages and high turnover, benefits that improve quality of life are noticed. Workers see when an employer invests in their health in ways that make a measurable difference. In a tight labor market, that can become a differentiator.

The stakes land hard on the people who keep the country running while others are asleep. The bus drivers driving in the dark, the workers stocking shelves before sunrise—these workers aren’t exhausted by choice. They’re exhausted because the system hasn’t prioritized making sleep healthcare accessible.

Diagnostic tools exist, and the science supports them. What’s needed now is the will to use them—before fatigue turns into something more expensive, more dangerous, and harder to undo.

Shift Work Sleep Disorder SWSD sleep disorders workforce health undiagnosed sleep apnea absenteeism workplace injuries at-home sleep study polysomnography healthcare access labor retention